Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2021-08-23 00:00:00 ET · period of report 2021-08-20 · accession 0001214659-21-008900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-23 | 2021-08-20 | ALLO | WITTE OWEN N. | Dir | S - Sale | $23.47 | -10.0K | 231.2K | -4% | -$234.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-20 | S | D | 5,000 | $23.24 | 226,182 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-20 | S | D | 5,000 | $23.70 | 231,182 | D | — | — |